Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 -12.00M
June 30, 2026 -10.55M
March 31, 2026 -14.38M
December 31, 2025 -15.64M
September 30, 2025 -12.14M
June 30, 2025 -11.15M
March 31, 2025 -15.43M
December 31, 2024 -5.521M
September 30, 2024 -7.555M
June 30, 2024 -0.667M
March 31, 2024 -1.819M
December 31, 2023 -0.947M
September 30, 2023 3.49M
June 30, 2023 -7.965M
Date Value
March 31, 2023 -15.18M
December 31, 2022 -8.449M
September 30, 2022 -4.175M
June 30, 2022 -13.97M
March 31, 2022 -10.78M
December 31, 2021 -7.884M
September 30, 2021 -12.97M
June 30, 2021 -8.481M
March 31, 2021 -6.74M
December 31, 2020
September 30, 2020 -2.381M
June 30, 2020 -3.768M
March 31, 2020 -2.325M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Korsana Biosciences, Inc. -46.83M
Cullinan Therapeutics, Inc. -43.08M
Q32 Bio, Inc. -4.418M
Oncolytics Biotech, Inc. -6.754M
Sangamo Therapeutics, Inc. -19.28M